Treating habit disorders

Details Treating habit disorders Treating habit disorders

1991-01-15

1992-05-19

Friedman, S. J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514320, 514427, 514432, A61K 3138, A61K 3140, A61K 31445, A61K 31495

Patent

active

051149427

ABSTRACT:
A method for treating habit disorders in a human patient comprising administering to the patient an antihabitual amount of a pharmaceutically active compound, which results in activation of a brain reward system, e.g., flupenthixol, or esters thereof or pharmaceutically acceptable salts thereof, either alone or in admixture with a physiologically acceptable diluent.

REFERENCES:
patent: 2554736 (1951-05-01), Haefliger et al.
patent: 3058979 (1962-10-01), Ullyot
patent: 3192204 (1965-06-01), Craig et al.
patent: 3194733 (1965-07-01), Yale et al.
patent: 3196157 (1965-07-01), Janssen et al.
patent: 3238216 (1966-03-01), Janssen et al.
patent: 3310553 (1967-03-01), Bloom et al.
patent: 3412193 (1968-11-01), Coppola
patent: 3438991 (1969-04-01), Janssen et al.
patent: 3546226 (1970-12-01), Schmutz et al.
patent: 3663696 (1972-05-01), Howell et al.
Evolving Conceptualizations of Cocaine Dependence; Frank H. Gawin, the Yale Journal of Biology and Medicine Inc., pp. 123-136, 1988.
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers; F. Gawin & H. Kleber; Arch Gen Psychiatry, vol. 43, Feb. 1986, pp. 107-113.
Desipramine Facilitation of Initial Cocaine Abstinence, F. Gawin & H. Kleber; Arch Gen Psychiatry, vol. 46, Feb. 1989, pp. 117-121.
Depression-Inducing and Antidepressive Effects of Neuroleptics, Neuropsychobiology 10: pp. 131-136, Poldinger S. Sieberns (1983).
Flupenthixol Decanoate in Schizophrenia; H. R. Trueman & M. G. Valentine; Brit. F. Psychiat. (1974), 124, pp. 58-59.
Major Tranquilizers Used As Antidepressants, Mary M. Robertson & M. R. Trimble, Journal of Affective Disorders, 4 (1982) pp. 173-193; Elsevier Biomedical Press.
A Controlled Comparison of Flupenthixol and Amitriptyline in Depressed Outpatients; J. Young, British Medical Journal, 1976, pp. 1116-1118, vol. 1.
SCRIP No. 822, Aug. 22, 1983, p. 2.
Central Nervous System, p. 78.
The Merck Index, pp. 599-600.
Lundbeck Limited, pp. 684-685.
Chemindex Plug, p. 407.
Symptomatic Relief with Flupentixol (Fluanxol) of the Anxious-Algetic-Depressive Syndrome Complex in Neurotic States; V. Predescu; Acta Psychiat. Scand (1973) 49, pp. 15-27.
A Double-Blind Comparison of Flupenthixol Nortriptyline and Diazepam in Neurotic Depression; D. Johnson; Acts Psychiat Scand, (1979) 59, pp. 1-8.
Objective and Subjective Assessments of the Effects of Flupentixol and Benzodiazepines on Human Psychomotor Performance; M. Mattila Psychopharmacology (1988) 95: pp. 323-328.
Flupenthixol Versus Combined Fluphenazine-Nortriptyline in Depressive Illness; Practioner, Mar. 1981, vol. 225, J. Conway, pp. 400-404.
Repeated Cocaine Administration Results in Supersensitivity of Straital D-2 Dopamine Autoreceptors to Pergolide, Linda Dwoskin; 1988 Pergamon Journals Ltd.; Life Sciences, vol. 42, pp. 255-262.
A Controlled Comparison of Flupenthixol Decanoate Infections and Oral Amitriptyline in Depressed Out-Patients; W. Tam Young; Brit. J. Psychiat, (1982), 140, pp. 287-291.

Affiliated with

Also associated with

Rating

Treating habit disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating habit disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating habit disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2417589